188 related articles for article (PubMed ID: 31974802)
1. Implantation of carmustine wafers (Gliadel
Champeaux C; Weller J
J Neurooncol; 2020 Mar; 147(1):159-169. PubMed ID: 31974802
[TBL] [Abstract][Full Text] [Related]
2. Recurrent high grade glioma surgery with carmustine wafers implantation: a long-term nationwide retrospective study.
Champeaux-Depond C; Jecko V; Weller J; Constantinou P; Tuppin P; Metellus P
J Neurooncol; 2023 Apr; 162(2):343-352. PubMed ID: 36991304
[TBL] [Abstract][Full Text] [Related]
3. Newly Diagnosed High-Grade Glioma Surgery with Carmustine Wafers Implantation. A Long-Term Nationwide Retrospective Study.
Champeaux-Depond C; Jecko V; Weller J; Constantinou P; Tuppin P; Metellus P
World Neurosurg; 2023 May; 173():e778-e786. PubMed ID: 36906091
[TBL] [Abstract][Full Text] [Related]
4. Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis.
Chowdhary SA; Ryken T; Newton HB
J Neurooncol; 2015 Apr; 122(2):367-82. PubMed ID: 25630625
[TBL] [Abstract][Full Text] [Related]
5. Retrospective comparison of chemoradiotherapy followed by adjuvant chemotherapy, with or without prior gliadel implantation (carmustine) after initial surgery in patients with newly diagnosed high-grade gliomas.
Noël G; Schott R; Froelich S; Gaub MP; Boyer P; Fischer-Lokou D; Dufour P; Kehrli P; Maitrot D
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):749-55. PubMed ID: 21300471
[TBL] [Abstract][Full Text] [Related]
6. Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review.
Ashby LS; Smith KA; Stea B
World J Surg Oncol; 2016 Aug; 14(1):225. PubMed ID: 27557526
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of serial changes on computed tomography and magnetic resonance imaging after implantation of carmustine wafers in patients with malignant gliomas for differential diagnosis of tumor recurrence.
Ohue S; Kohno S; Inoue A; Yamashita D; Suehiro S; Seno T; Kumon Y; Kikuchi K; Ohnishi T
J Neurooncol; 2016 Jan; 126(1):119-126. PubMed ID: 26384812
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
9. Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient management.
Kleinberg LR; Weingart J; Burger P; Carson K; Grossman SA; Li K; Olivi A; Wharam MD; Brem H
Cancer Invest; 2004; 22(1):1-9. PubMed ID: 15069758
[TBL] [Abstract][Full Text] [Related]
10. The effects of the NICE Technology Appraisal 121 (gliadel and temozolomide) on survival in high-grade glioma.
Barr JG; Grundy PL
Br J Neurosurg; 2012 Dec; 26(6):818-22. PubMed ID: 22715955
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy wafers for high grade glioma.
Hart MG; Grant R; Garside R; Rogers G; Somerville M; Stein K
Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD007294. PubMed ID: 21412902
[TBL] [Abstract][Full Text] [Related]
12. The first 3 months after BCNU wafers implantation in high-grade glioma patients: clinical and radiological considerations on a clinical series.
Della Puppa A; Rossetto M; Ciccarino P; Del Moro G; Rotilio A; Manara R; Paola Gardiman M; Denaro L; d'Avella D; Scienza R
Acta Neurochir (Wien); 2010 Nov; 152(11):1923-31. PubMed ID: 20703889
[TBL] [Abstract][Full Text] [Related]
13. [Risk Factors for Adverse Events after Implantation of BCNU Wafers in High-grade Gliomas].
Yoshida M; Yamaguchi S; Ishi Y; Endo S; Motegi H; Kobayashi H; Asaoka K; Kamoshima Y; Terasaka S; Houkin K
No Shinkei Geka; 2015 Jul; 43(7):603-10. PubMed ID: 26136324
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapeutic wafers for High Grade Glioma.
Hart MG; Grant R; Garside R; Rogers G; Somerville M; Stein K
Cochrane Database Syst Rev; 2008 Jul; (3):CD007294. PubMed ID: 18646178
[TBL] [Abstract][Full Text] [Related]
15. Carmustine wafer implantation when surgical cavity is communicating with cerebral ventricles: technical considerations on a clinical series.
Della Puppa A; Rossetto M; Ciccarino P; Denaro L; Rotilio A; d'Avella D; Scienza R
World Neurosurg; 2011; 76(1-2):156-9; discussion 67-8. PubMed ID: 21839967
[TBL] [Abstract][Full Text] [Related]
16. Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience.
Sabel M; Giese A
Curr Med Res Opin; 2008 Nov; 24(11):3239-57. PubMed ID: 18940042
[TBL] [Abstract][Full Text] [Related]
17. Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies.
Lin SH; Kleinberg LR
Expert Rev Anticancer Ther; 2008 Mar; 8(3):343-59. PubMed ID: 18366283
[TBL] [Abstract][Full Text] [Related]
18. Polymeric drug delivery for the treatment of glioblastoma.
Wait SD; Prabhu RS; Burri SH; Atkins TG; Asher AL
Neuro Oncol; 2015 Mar; 17 Suppl 2(Suppl 2):ii9-ii23. PubMed ID: 25746091
[TBL] [Abstract][Full Text] [Related]
19. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial.
Westphal M; Ram Z; Riddle V; Hilt D; Bortey E;
Acta Neurochir (Wien); 2006 Mar; 148(3):269-75; discussion 275. PubMed ID: 16482400
[TBL] [Abstract][Full Text] [Related]
20. Delayed post-operative haemorrhage after carmustine wafer implantation: a case series from two UK centres.
Shah RS; Homapour B; Casselden E; Barr JG; Grundy PL; Brydon HL
Br J Neurosurg; 2014 Aug; 28(4):488-94. PubMed ID: 24313309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]